Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Nitta Gelatin Inc.. A complete text table follows the diagram.
Revenue fell 6.3%, but operating income rose 9.2% as North American profitability improved and low-return food-material volume was rationalized.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Gelatin | 1 | 13.5B | 72.9% of reported total |
| Collagen peptides | 1 | 3.3B | 17.9% of reported total |
| Food materials | 1 | 1.5B | 8.2% of reported total |
| Biomedical | 1 | 183M | 1.0% of reported total |
| Other & rounding | 1 | 2M | 0.0% of reported total |
| Net sales | 2 | 18.5B | JPY18.499B six-month gelatin, collagen and biomaterials sales |
| Collagen platform | 3 | 18.5B | Gelatin, collagen peptides, food materials and biomedical applications |
| Other & rounding | 3 | 2M | Product categories are disclosed in rounded millions of yen and reconcile to reported net sales with a JPY2M residual. |
| From | To | Value |
|---|---|---|
| Gelatin | Net sales | 13.5B |
| Collagen peptides | Net sales | 3.3B |
| Food materials | Net sales | 1.5B |
| Biomedical | Net sales | 183M |
| Other & rounding | Net sales | 2M |
| Net sales | Collagen platform | 18.5B |
| Net sales | Other & rounding | 2M |